Arkolith/Insider Trading/ZVRA/Form 4

McFarlane Neil F.

President and CEO, DirectorZEVRA THERAPEUTICS, INC. (ZVRA) · full profile →Form 4 · filed Feb 2, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$854K
Net Open-Market Flow
-$854K
Transactions
5
2 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 2, 2026Sell(S)91K$9.38$854K364K
Jan 31, 2026Option exercise(M)233K——455K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 31, 2026Option exercise(M)233K—$0233K
Jan 29, 2026Grant(A)125K—$0125K
Jan 29, 2026Grant(A)250K—$0250K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001681098-26-000002) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML